관련문헌 등
·Basic & Pharmacology 14e. 2018.
·Conn’s Current Therapy. 2020.
·MASAC(The Medical and Scientific Advisory Council) Recommendations concerning Products Licensed for the Treatment of Hemophilia and Other Bleeding Disorder. 2018.
·Santagostino E. et al. Long-acting recombinant coagulation factor IX albumin fusion protein(rIX-FP) in hemophilia B: results of a phase 3 trial. Blood. 2016 April 7; 127(4): 1761-9
·Kanet g. et al. Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Thromb Haemost. 2016 Sep 27; 116(4): 659-68
·대한혈액학회 (대혈학 2020-206, 2020.11.05.)
·한국혈전지혈학회 (혈지 20-034, 2020.10.14.)
·Goldman-Cecil Medicine. 26th edition, 2020
·Middleton's Allergy Principles and Practice, 2020
·Textbook of Allergy for the Clinician, 2021
·Global Initiative for Asthma, global strategy for asthma management and prevention(GINA guideline) 2022
·천식 진료지침 5차 개정. 대한결핵및호흡기학회, 2022
·한국천식진료지침. 대한천식알레르기학회, 2021
·SIGN158 British guideline on the management of asthma, 2019
·Bleecker ER, et al. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial Lancet 2016; 388: 2115？27
·Nair P, et al. Oral Glucocorticoid？Sparing Effect of Benralizumab in Severe Asthma N Engl J Med 2017;376:2448-58.
·Kenneth R. Chapman, et al. Allergy. 2019;74:1716？1726.
·대한천식알레르기학회 (대알학 2022-109호, 2022.10.20.), 대한결핵및호흡기학회(결학 제2022-363호, 2022.10.26.)
·NICE(2019), CADTH(2019), PBAC(2020)